CME vs. CBOE, COIN, MKTX, NDAQ, NVDA, IBKR, ICE, MCO, MSCI, and AROW
Should you be buying CME Group stock or one of its competitors? The main competitors of CME Group include Cboe Global Markets (CBOE), Coinbase Global (COIN), MarketAxess (MKTX), Nasdaq (NDAQ), NVIDIA (NVDA), Interactive Brokers Group (IBKR), Intercontinental Exchange (ICE), Moody's (MCO), MSCI (MSCI), and Arrow Financial (AROW).
CME Group vs. Its Competitors
CME Group (NASDAQ:CME) and Cboe Global Markets (BATS:CBOE) are related large-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.
87.8% of CME Group shares are owned by institutional investors. Comparatively, 81.7% of Cboe Global Markets shares are owned by institutional investors. 0.3% of CME Group shares are owned by insiders. Comparatively, 0.5% of Cboe Global Markets shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
CME Group has a net margin of 58.48% compared to Cboe Global Markets' net margin of 5.77%. Cboe Global Markets' return on equity of 20.05% beat CME Group's return on equity.
CME Group has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Cboe Global Markets has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.
CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.9%. Cboe Global Markets pays an annual dividend of $1.92 per share and has a dividend yield of 0.8%. CME Group pays out 48.4% of its earnings in the form of a dividend. Cboe Global Markets pays out 99.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cboe Global Markets has increased its dividend for 1 consecutive years. CME Group is clearly the better dividend stock, given its higher yield and lower payout ratio.
CME Group currently has a consensus target price of $261.93, indicating a potential downside of 2.16%. Cboe Global Markets has a consensus target price of $217.57, indicating a potential downside of 7.20%. Given CME Group's higher possible upside, analysts clearly believe CME Group is more favorable than Cboe Global Markets.
CME Group has higher revenue and earnings than Cboe Global Markets. CME Group is trading at a lower price-to-earnings ratio than Cboe Global Markets, indicating that it is currently the more affordable of the two stocks.
In the previous week, CME Group had 38 more articles in the media than Cboe Global Markets. MarketBeat recorded 38 mentions for CME Group and 0 mentions for Cboe Global Markets. CME Group's average media sentiment score of 1.26 beat Cboe Global Markets' score of 0.00 indicating that CME Group is being referred to more favorably in the media.
Summary
CME Group beats Cboe Global Markets on 11 of the 18 factors compared between the two stocks.
Get CME Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CME and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CME and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CME Group Competitors List
Related Companies and Tools
This page (NASDAQ:CME) was last updated on 9/3/2025 by MarketBeat.com Staff
